GlaxoSmithKline failed to disclose safety data about Avandia, Wellbutrin, and Paxil, thus allegedly violating the False Claims Act, which they settled with $2.3 billion.
GlaxoSmithKline failed to disclose safety data about Avandia, Wellbutrin, and Paxil, thus allegedly violating the False Claims Act, which they settled with $2.3 billion.